Meta‐analysis: prevalence of, and risk factors for, non‐alcoholic fatty liver disease in patients with inflammatory bowel disease
Alimentary Pharmacology & Therapeutics2022Vol. 55(8), pp. 894–907
Citations Over TimeTop 10% of 2022 papers
Abstract
Up to one-third of patients with IBD experienced NAFLD worldwide. The risk of NAFLD was two times higher in IBD patients versus healthy subjects.
Related Papers
- → Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?(2012)215 cited
- → Non-alcoholic steatohepatitis(2006)15 cited
- → Categorization and complication of non-alcoholic fatty liver disease(2022)1 cited
- → Mo1015 Liver Function Breath Tests for Differentiation of Steatohepatitis From Simple Fatty Liver in Patients With Non-Alcoholic Fatty Liver Disease(2013)
- → Manifestation of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Different Dietary Mouse Models(2016)